| Code | 9255C | ||||||||||
| MA number | 59/0323/18-S | ||||||||||
| Product Form: | cps dur 21x25 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 27.09.2018 |
| SPC: |
SPC_Lenalidomid_Sandoz_10 mg_15 mg_25 mg_11.2023.pdf
|
| PIL: |
PIL_Lenalidomid_Sandoz_10 mg_15 mg_25 mg_11.2023.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Príručka_pre_pacienta.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Príručka_pre_zdravotníckych_pracovníkov.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Sprievodca_pri_predpisovaní.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Súhrnný_kontrolný_zoznam.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Informačný_balík_pre_zdravotníckych pracovníkov.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Často_kladené_otázky.pdf
|
| Dokument: |
Lenalidomid_Sandoz_Karta_pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 24.04.2023 |
